|
1
|
Qiu W: Oral and maxillofacial surgery
(6th). People's Medical Publishing House. Beijing: 274–275.
2008.
|
|
2
|
Girdler NM: Oral ulceration: Benign or
malignant? A diagnostic dilemma. Br Dent J. 168:3861990. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlito A, Shaha AR and Rinaldo A: The
incidence of lymph node micrometastases in patients pathologically
staged No in cancer of oral cavity and oropharynx. Oral Oncol.
38:3–5. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kademani D: Oral cancer. Mayo Clin Proc.
82:878–887. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Becker MT, Shores CG, Yu KK and Yarbrough
WG: Molecular assay to detect metastatic head and neck squamous
cell carcinoma. Arch Otolaryngol Head Neck Surg. 130:21–27. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Németh Z, Velich N, Bogdan S, Ujpál M,
Szabó G and Suba ZS: The prognostic role of clinical, morphological
and molecular markers in oral squamous cell tumors. Neoplasma.
52:95–102. 2005.PubMed/NCBI
|
|
7
|
He H, Huang J, Ping F, Chen G, Zhang S and
Dong Y: Anatomical and clinical study of lingual arterial
chemoembolization for tongue carcinoma. Oral Surg Oral Med Oral
Pathol Oral Radiol Endod. 103:e1–e5. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mano H: Discovery and clinical application
of mutations in the cancer genome. Nihon Rinsho. 73:1251–1255.
2015.(In Japanese). PubMed/NCBI
|
|
9
|
Ohtsuka M, Ling H, Doki Y, Mori M and
Calin GA: MicroRNA processing and human cancer. J Clin Med.
4:1651–1667. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li JD, Liang RY, Zhao YP and Xu YL:
Correlation analysis of VEGF and PTEN expression in gingival
carcinoma. Shanghai Kou Qiang Yi Xue. 23:619–623. 2014.(In
Chinese). PubMed/NCBI
|
|
11
|
Boldrup L, Coates PJ, Wahlgren M, Laurell
G and Nylander K: Subsite-based alterations in miR-21, miR-125b,
and miR-203 in squamous cell carcinoma of the oral cavity and
correlation to important target proteins. J Carcinog. 11:182012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang KC, Xi HQ, Cui JX, Shen WS, Li JY,
Wei B and Chen L: Hemolysis-free plasma miR-214 as novel biomarker
of gastric cancer and is correlated with distant metastasis. Am J
Cancer Res. 5:821–829. 2015.PubMed/NCBI
|
|
13
|
Wang F, Lv P, Liu X, Zhu M and Qiu X:
microRNA-214 enhances the invasion ability of breast cancer cells
by targeting p53. Int J Mol Med. 35:1395–1402. 2015.PubMed/NCBI
|
|
14
|
Wang J, Zhang X, Wang L, Yang Y, Dong Z,
Wang H, Du L and Wang C: MicroRNA-214 suppresses oncogenesis and
exerts impact on prognosis by targeting PDRG1 in bladder cancer.
PLoS One. 10:e01180862015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wan DY, Zhang Z and Yang HH:
Cardioprotective effect of miR-214 in myocardial ischemic
postconditioning by down-regulation of hypoxia inducible factor 1,
alpha subunit inhibitor. Cell Mol Biol (Noisy-le-grand). 61:1–6.
2015.PubMed/NCBI
|
|
16
|
Izawa T, Horiuchi T, Atarashi M, Kuwamura
M and Yamate J: Anti-fibrotic role of miR-214 in
Thioacetamide-induced liver cirrhosis in rats. Toxicol Pathol.
43:844–851. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Squarize CH, Castilho RM and Santos Pinto
D Jr: Immunohistochemical evidence of PTEN in oral squamous cell
carcinoma and its correlation with the histological malignancy
grading system. J Oral Pathol Med. 31:379–384. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li DM and Sun H: PTEN/MMAC1/TEP1
suppresses the tumorigenicity and induces G1 cell cycle arrest in
human glioblastoma cells. Proc Natl Acad Sci USA. 95:15406–15411.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Di Cristofano A and Pandolfi PP: The
multiple roles of PTEN in tumor suppression. Cell. 100:387–390.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stiles B, Gilman V, Khanzenzon N, Lesche
R, Li A, Qiao R, Liu X and Wu H: Essential role of AKT-1/protein
kinase B in PTEN-controlled tumorigenesis. Mol Cell Biol.
22:3842–3851. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Davies MA, Koul D, Dhesi H, Berman R,
McDonnell TJ, McConkey D, Yung WK and Steck PA: Regulation of
Akt/PKB activity, cellular growth, and apoptosis in prostate
carcinoma cells by MMAC/PTEN1. Cancer Res. 59:2551–2556.
1999.PubMed/NCBI
|
|
22
|
Tamura M, Gu J, Takino T and Yamada KM:
Tumor suppressor PTEN inhibition of cell invasion, migration, and
growth: Differential involvement of focal adhesion kinase and
p130Cas. Cancer Res. 59:442–449. 1999.PubMed/NCBI
|
|
23
|
McCubrey JA, Steelman LS, Abrams SL, Lee
JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA,
D'Assoro AB, et al: Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT
pathways in malignant transformation and drug resistance. Adv
Enzyme Regul. 46:249–279. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Punnoose EA, Ferraldeschi R,
Szafer-Glusman E, Tucker EK, Mohan S, Flohr P, Riisnaes R, Miranda
S, Figueiredo I, Rodrigues DN, et al: PTEN loss in circulating
tumor cells correlates with PTEN loss in fresh tumor tissue from
castration-resistant prostate cancer patients. Br J Cancer.
113:1225–1233. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li J, Yen C, Liaw D, Podsypanina K, Bose
S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, et al:
PTEN, a putative protein tyrosine phosphatase gene mutated in human
brain, breast, and prostate cancer. Science. 275:1943–1947. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mutter GL, Lin MC, Fitzgerald JT, Kum JB,
Baak JP, Lees JA, Weng LP and Eng C: Altered PTEN expression as a
diagnostic marker for the earliest endometrial precancers. J Natl
Cancer Inst. 92:924–930. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Duerr EM, Rollbrocker B, Hayashi Y, Peters
N, Meyer-Puttlitz B, Louis DN, Schramm J, Wiestler OD, Parsons R,
Eng C and von Deimling A: PTEN mutations in gliomas and
glioneuronal tumors. Oncogene. 16:2259–2264. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tsao H, Zhang X, Benoit E and Haluska FG:
Identification of PTEN/MMAC1 alterations in uncultured melanomas
and melanoma cell lines. Oncogene. 16:3397–3402. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rizvi MM, Alam MS, Ali A, Mehdi SJ, Batra
S and Mandal AK: Aberrant promoter methylation and inactivation of
PTEN gene in cervical carcinoma from Indian population. J Cancer
Res Clin Oncol. 137:1255–1262. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang XF, Xin Y and Mao LL:
Clinicopathological significance of PTEN and caspase-3 expressions
in breast cancer. Chin Med Sci J. 23:95–102. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bowen KA, Doan HQ, Zhou BP, Wang Q, Zhou
Y, Rychahou PG and Evers BM: PTEN loss induces
epithelial-mesenchymal transition in human colon cancer cells.
Anticancer Res. 29:4439–4449. 2009.PubMed/NCBI
|
|
32
|
Ren W, Qiang C, Gao L, Li SM, Zhang LM,
Wang XL, Dong JW, Chen C, Liu CY and Zhi KQ: Circulating
microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are
promising novel biomarkers for detection of oral squamous cell
carcinoma. Biomarkers. 19:590–596. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-tie quantitative PCR and
the 2(−Delta Delta C (T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
León LE and Calligaris SD: Visualization
and analysis of MiRNA-targets interactions networks. Methods Mol
Biol. 1509:209–220. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Falconieri G, Luna MA, Pizzolitto S,
DeMaglio G, Angione V and Rocco M: Eosinophil-rich squamous
carcinoma of the oral cavity: A study of 13 cases and delineation
of a possible new microscopic entity. Ann Diagn Pathol. 12:322–327.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kalnins IK, Leonard AG, Sako K, Razack MS
and Shedd DP: Correlation between prognosis and degree of lymph
node involvement in carcinoma of the oral cavity. Am J Surg.
134:450–454. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Estimating the world cancer burden: Globocan 2000. Int J Cancer.
94:153–156. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rautava J, Luukkaa M, Heikinheimo K, Alin
J, Grenman R and Happonen RP: Squamous cell carcinomas arising from
different types of oral epithelia differ in their tumor and patient
characteristics and survival. Oral Oncol. 43:911–919. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yoshida R, Nakayama H, Nagata M, Hirosue
A, Tanaka T, Kawahara K, Nakagawa Y, Matsuoka Y, Sakata J, Arita H,
et al: Overexpression of nucleostemin contributes to an advanced
malignant phenotype and a poor prognosis in oral squamous cell
carcinoma. Br J Cancer. 111:2308–2315. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kirita T, Yamanaka Y, Imai Y, Yamakawa N,
Aoki K, Nakagawa Y, Yagyuu T and Hasegawa M: Preoperative
concurrent chemoradiotherapy for stages II–IV oral squamous cell
carcinoma: A retrospective analysis and the future possibility of
this treatment strategy. Int J Oral Maxillofac Surg. 41:421–428.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cheng YS, Rees T and Wright J: A review of
research on salivary biomarkers for oral cancer detection. Clin
Transl Med. 3:32014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Steck PA, Pershouse MA, Jasser SA, Yung
WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T,
et al: Identification of a candidate tumour suppressor gene, MMAC1,
at chromosome 10q23.3 that is mutated in multiple advanced cancers.
Nat Genet. 15:356–362. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li DM and Sun H: PTEN, encoded by a
candidate tumor suppressor locus, is a novel protein tyrosine
phosphatase regulated by transforming growth factor beta. Cancer
Res. 57:2124–2129. 1997.PubMed/NCBI
|
|
44
|
Wang YF and Tang WP: Progress of PTEN gene
and oral and maxillofacial tumors. Shi Yong Lin Chuang Yi Xue.
11:125–127. 2010.
|
|
45
|
Liu K, Liu S, Zhang W, Jia B, Tan L, Jin Z
and Liu Y: miR-494 promotes cell proliferation, migration and
invasion, and increased sorafenib resistance in hepatocellular
carcinoma by targeting PTEN. Oncol Rep. 34:1003–1010.
2015.PubMed/NCBI
|
|
46
|
Howe K: Extraction of miRNAs from
formalin-fixed paraffin-embedded (FFPE) tissues. Methods Mol Biol.
1509:17–24. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Deng H, Liu Q, Wang X, Huang R, Liu H, Lin
Q, Zhou X and Xing D: Quantum dots-labeled strip biosensor for
rapid and sensitive detection of microRNA based on target-recycled
nonenzymatic amplification strategy. Biosens Bioelectron.
87:931–940. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Rissland OS: The organization and
regulation of mRNA-protein complexes. Wiley Interdiscip Rev RNA.
8:2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang TS, Yang XH, Wang XD, Wang YL, Zhou B
and Song ZS: MiR-214 regulate gastric cancer cell proliferation,
migration and invasion by targeting PTEN. Cancer Cell Int.
13:682013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Schwarzenbach H, Milde-Langosch K,
Steinbach B, Müller V and Pantel K: Diagnostic potential of
PTEN-targeting miR-214 in the blood of breast cancer patients.
Breast Cancer Res Treat. 134:933–941. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yang H, Kong W, He L, Zhao JJ, O'Donnell
JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV and Cheng JQ:
MicroRNA expression profiling in human ovarian cancer: miR-214
induces cell survival and cisplatin resistance by targeting PTEN.
Cancer Res. 68:425–433. 2008. View Article : Google Scholar : PubMed/NCBI
|
